Tag Archives: SHPG

Shire Receives a Buy from BTIG

In a report issued on April 26, Tim Chiang from BTIG maintained a Buy rating on Shire (NASDAQ: SHPG), with a price target of $195. The company’s shares closed on Friday at $161.66. According to TipRanks.com, Chiang is a 3-star

Cantor Fitzgerald Sticks to Its Buy Rating for Shire

In a report released today, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Shire (NASDAQ: SHPG), with a price target of $222. The company’s shares closed yesterday at $162.54. Chen said: “Though it has not been confirmed by

B.Riley FBR Maintains Their Buy Rating on Shire

B.Riley FBR analyst David Buck maintained a Buy rating on Shire (NASDAQ: SHPG) today and set a price target of $181. The company’s shares opened today at $152.30. Buck noted: “We see Shire ADS as undervalued on fundamentals given persistent

B.Riley FBR Thinks Shire’s Stock is Going to Recover

B.Riley FBR analyst David Buck reiterated a Buy rating on Shire (NASDAQ: SHPG) today. The company’s shares opened today at $127.56, close to its 52-week low of $123.73. Buck said: “Buy-rated Shire ($181 PT) announced FDA acceptance for the lanadelumab

B.Riley FBR Sticks to Its Buy Rating for Shire

In a report released today, David Buck from B.Riley FBR maintained a Buy rating on Shire (NASDAQ: SHPG), with a price target of $181. The company’s shares opened today at $135.30. Buck said: “We update thoughts on Shire (Buy, $181

Analysts Offer Insights on Healthcare Companies: Shire (NASDAQ: SHPG), Irhythm Technologies (NASDAQ: IRTC) and Agios Pharma (NASDAQ: AGIO)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Shire (NASDAQ: SHPG), Irhythm Technologies (NASDAQ: IRTC) and Agios Pharma (NASDAQ: AGIO) with bullish sentiments. Shire (NASDAQ: SHPG) In a report released